Daniel A. Rushing, MD
Professor of Clinical Medicine
Indiana Cancer Pavilion, Suite 473 535 Barnhill Dr
Indianapolis, IN 46202-5289
Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers.
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma.
Physical, psychological, and spiritual transformation at life's end: toward a theory of convergence.
American Board of Internal Medicine - Hospice and Palliative Medicine